Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Nicholson

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in Pharmacology|November 21, 2001
The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formationT J Girard, N S Nicholson
Journal of Immunological Methods|June 13, 1988
A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophilsS K Paulson, N S Nicholson
Thrombosis Research|July 15, 1984
Effect of the stable endoperoxide analog U-46619 on prostacyclin production and cyclic AMP levels in bovine endothelial cellsN S Nicholson, S L Smith, G C Fuller
Brain and Language|July 1, 1990
Hemispheric involvement in shadowing vs. interpretation: a time-sharing study of simultaneous interpreters with matched bilingual and monolingual controlsA Green, N S Nicholson, J Vaid, et al.
Developmental Medicine and Child Neurology|March 1, 1994
Biotinidase deficiency: early neurological presentationJ E Collins, N S Nicholson, N Dalton, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Evaluation of a stable 5-F prostacyclin analogue as an antithrombotic agent in haemodialysisN S Nicholson, S L Smith, B B Taite, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 27, 1999
Whole-blood assays for evaluation of thromboxane synthase inhibitionE G Spokas, N S Nicholson, O D Suleymanov, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1993
Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregationS Panzer-Knodle, B B Taite, D V Mehrotra, et al.
Circulation|January 1, 1996
The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosisL G Frederick, O D Suleymanov, L W King, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosisL P Feigen, N S Nicholson, L W King, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in Pharmacology|November 21, 2001
The role of tissue factor/factor VIIa in the pathophysiology of acute thrombotic formationT J Girard, N S Nicholson
Journal of Immunological Methods|June 13, 1988
A radioreceptor binding assay for measurement of platelet-activating factor synthesis by human neutrophilsS K Paulson, N S Nicholson
Thrombosis Research|July 15, 1984
Effect of the stable endoperoxide analog U-46619 on prostacyclin production and cyclic AMP levels in bovine endothelial cellsN S Nicholson, S L Smith, G C Fuller
Brain and Language|July 1, 1990
Hemispheric involvement in shadowing vs. interpretation: a time-sharing study of simultaneous interpreters with matched bilingual and monolingual controlsA Green, N S Nicholson, J Vaid, et al.
Developmental Medicine and Child Neurology|March 1, 1994
Biotinidase deficiency: early neurological presentationJ E Collins, N S Nicholson, N Dalton, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
Evaluation of a stable 5-F prostacyclin analogue as an antithrombotic agent in haemodialysisN S Nicholson, S L Smith, B B Taite, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 27, 1999
Whole-blood assays for evaluation of thromboxane synthase inhibitionE G Spokas, N S Nicholson, O D Suleymanov, et al.
Journal of Pharmacological and Toxicological Methods|September 1, 1993
Species variation in the effect of glycoprotein IIb/IIIa antagonists on inhibition of platelet aggregationS Panzer-Knodle, B B Taite, D V Mehrotra, et al.
Circulation|January 1, 1996
The protective dose of the potent GPIIb/IIIa antagonist SC-54701A is reduced when used in combination with aspirin and heparin in a canine model of coronary artery thrombosisL G Frederick, O D Suleymanov, L W King, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
SC-49992, a mimetic of the peptide arginine-glycine-aspartic acid-phenylalanine that blocks platelet aggregation, enhances recombinant tissue plasminogen activator-induced thrombolysis and prevents reocclusion in a canine model of coronary artery thrombosisL P Feigen, N S Nicholson, L W King, et al.
Pageof 3